1. Market Research
  2. > Healthcare Market Trends
  3. > Agfa-Gevaert N.V. - Strategy and SWOT Report

Agfa-Gevaert N.V. - Strategy and SWOT Report

  • January 2016
  • -
  • MarketLine
  • -
  • 32 pages

Introduction

Agfa-Gevaert N.V. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Features:

- Detailed information on Agfa-Gevaert N.V. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Agfa-Gevaert N.V. in the form of a SWOT analysis

- An in-depth view of the business model of Agfa-Gevaert N.V. including a breakdown and examination of key business segments

- Intelligence on Agfa-Gevaert N.V.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Agfa-Gevaert N.V., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Agfa-Gevaert N.V. (Agfa or "the company") is a developer, producer, and distributor of a range of analog and digital imaging systems and information technology (IT) solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications. The company operates in Europe, Americas, Africa, and Asia Pacific regions. It is headquartered in Mortsel, Belgium and employed 11,233 people as of December 31, 2014. The company recorded revenues of E2,620 million ($3,480.7 million) during the financial year ended December 2014 (FY2014), a decrease of 8.6% compared to FY2013. The operating profit of the company was E136 million ($180.7 million) in FY2014, a decrease of 16.6% compared to FY2013. The net profit of the company was E50 million ($66.4 million) in FY2014, an increase of 22% over FY2013.

Reasons to Purchase:

- Gain understanding of Agfa-Gevaert N.V. and the factors that influence its strategies

- Track strategic initiatives of the company and latest corporate news and actions

- Assess Agfa-Gevaert N.V. as a prospective partner, vendor or supplier

- Support sales activities by understanding your customers' businesses better

- Stay up to date on Agfa-Gevaert N.V.’s business structure, strategy and prospects

Table Of Contents

Agfa-Gevaert N.V. - Strategy and SWOT Report
Company Overview
Business Description
History
Key Employees and Biographies
Company View
Locations and Subsidiaries
SWOT Analysis
Revenue Analysis
Key Competitors
Major Products and Services

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hyperlipidemia - Pipeline Review, H2 2016

Hyperlipidemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Hyperlipidemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H2 2016’, provides an overview of the Hyperlipidemia pipeline landscape. The report provides ...

Tetanus - Pipeline Review, H2 2016

Tetanus - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Tetanus - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tetanus - Pipeline Review, H2 2016’, provides an overview of the Tetanus pipeline landscape. The report provides comprehensive ...

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016’, provides an overview ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.